CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1982; 32:66-77
doi: 10.3322/canjclin.32.2.66
© 1982 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drasga, R. E.
Right arrow Articles by Williams, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drasga, R. E.
Right arrow Articles by Williams, S. D.

CA: A Cancer Journal for Clinicians, Vol 32, 66-77, Copyright © 1982 by American Cancer Society

The Chemotherapy of Testicular Cancer

Ray E. Drasga M.D.1, Lawrence H. Einhorn M.D.2, and Stephen D. Williams M.D.3

1 Clinical Research Fellow in the Department of Medicine of Indiana University Medical Center in Indianapolis, Indiana.
2 Professor of the Department of Medicine of Indiana University Medical Center in Indianapolis, Indiana, American Cancer Society Clinical Professor of Oncology.
3 Department of Medicine of Indiana University Medical Center, and Chief of Medical Oncology of the Indianapolis Veteran's Administration Medical Center, in Indianapolis, Indiana.

The cure rate in stage I and stage II non-seminomatous testicular cancer should approach 100 percent. The data show that even without adjuvant chemotherapy almost all these patients can be cured. The role of aggressive adjuvant chemotherapy needs to be defined in a random, prospective study. In stage III disease, PVB resulted in a 70 percent cure rate in 296 patients. This cure rate is unparalleled in cancer treatment and represents a major advance in the field of medical oncology.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by American Cancer Society.